CM
DXCM icon

Crestline Management’s DexCom DXCM Stock Holding History

Crestline Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,591
Closed -$1.06M – 187
2024
Q4 		$1.06M Buy
+13,591
New +$1.01M 0.04% 404
2022
Q1 		– Sell
-16,704
Closed -$2.24M – 276
2021
Q4 		$2.24M Sell
16,704
-2,600
-13% -$374K 0.17% 110
2021
Q3 		$2.64M Buy
+19,304
New +$2.43M 0.25% 89

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Crestline Management's DXCM Position: Q1 2025 in Review

Crestline Management sold out of DexCom (DXCM) in Q1 2025, closing a stake of 13,591 shares — an estimated $1.06M sold.

Crestline Management first reported a position in DXCM in Q3 2021 and held it in 3 quarters. The position peaked at $2.64M in Q3 2021. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Crestline Management reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 13,591 DexCom shares in Q1 2025, an estimated $1.06M.
  • Crestline Management first reported a position in DexCom in Q3 2021 and held it in 3 quarters.
  • Crestline Management's DexCom position peaked at $2.64M in Q3 2021.
  • 932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.